KELLY THOMAS PATRICK (Chief Financial Officer) purchased 15K shares of XENON PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $559.7K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/1/2026ACC: 0001193125-26-410001
Officer· Chief Financial Officer
Since Oct 2025
+15K
Net shares
Net buyer
$559.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+15K
Price / share
$37.32
Trade value
$559.74K
% of position
New position
9/30/2026
0.00→15K
Total
Net shares
+15K
Net value
$559.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/30/2026 | P · Purchase | +15K | $37.32 | $559.74K | New position | 0.00 | 15K |
| Total | +15K | $559.74K | ||||||
Derivative Transactions0
No derivative transactions reported